top of page
The Longevity Industry will be the Biggest and Most Complex Industry in Human History
The Longevity industry will dwarf all other industries in both size and market capitalization and will require unprecedented sophistication in its approach for assessment and forecasting from the start to neutralize challenges and manifest opportunities
Longevity as New Government Strategy
Citizens of progressive technocracy driven countries can expect healthier, happier, and longer lives. As smart governments utilize progress in all sectors of the Longevity industry to maximize the health, wealth, and wellness of their citizens, Longevity will become a major electoral talking-point and policy priority that will determine the success of parties and politicians.
Specialized Metrics To Properly Assess AI-Pharma Startups
The level of sophistication used in due diligence should be on a par with the level of complexity in a given industry. AI-Pharma companies are 100 times as complex as FinTech companies. Methodologies used to assess them should be 100 times as rigorous.
DeepTech News Briefs
This article is part of a DeepTech Series by Margaretta Colangelo and Dmitry Kaminskiy.
DeepTech in Drug Discovery
“The drug discovery process consists of many phases and often takes decades. The probability of failure is very high at every stage. In preclinical phases the failure rates are over 99%. Our AI can be used in every one of these phases and in some cases lead to superhuman results. Our AI is exceptionally good at finding the molecular targets in specific diseases and inventing new chemistry.”
BioPharma Must Innovate or Die
Although pharmaceutical companies spend over $172 billion on research and development annually, over 90% of molecules discovered using traditional techniques fail in human clinical trials. Moreover, 75% of newly approved drugs are unable to cover the cost of development and some analysts predict that ROI in R&D may hit zero by 2020.
bottom of page